We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome.
- Authors
Rodrigues, Carlos Ewerton Maia; Bonfá, Eloisa; Caleiro, Maria Teresa Correia; Vendramini, Margarete B.; Bueno, Cleonice; Lopes, Jaqueline B.; de Carvalho, Jozélio Freire
- Abstract
Objective Metabolic syndrome (MetS) is highly prevalent in rheumatic diseases and is recognized as a new independent cardiovascular risk factor. This study was undertaken to determine the clinical significance of MetS in patients with primary antiphospholipid syndrome (APS). Methods Seventy-one primary APS patients and 73 age- and sex-matched healthy controls were included. Serum samples were tested for lipid profile, Lp(a), glucose, insulin, thyroid-stimulating hormone, free T4, erythrocyte sedimentation rate, C-reactive protein level, and uric acid. MetS was defined by the International Diabetes Federation criteria, and insulin resistance was established using the homeostasis model assessment index. Results The prevalence of MetS was 33.8%, and further comparison between primary APS patients with and without MetS revealed that the former had a higher frequency of arterial events (79.2% versus 42.6%; P = 0.003), angina (29.2% versus 2.1%; P = 0.002), and positive lupus anticoagulant antibody (95.8% versus 76.6%; P = 0.049). In addition, primary APS patients with MetS, as expected, had a higher prevalence of cardiovascular risk factors. On multivariate analysis, only MetS was independently associated with arterial events in primary APS. Conclusion Coexistence of primary APS and MetS seems to identify a subgroup of patients with higher risk of arterial events, suggesting that MetS may aggravate existing endothelial abnormalities of primary APS.
- Publication
Arthritis Care & Research, 2012, Vol 64, Issue 10, p1576
- ISSN
2151-464X
- Publication type
Article
- DOI
10.1002/acr.21701